Sclerostin Declines during Hemodialysis and Appears in Dialysate

Bernhard Bielesz,Till Hempfing,Heidi Kieweg,Rodrig Marculescu,Martin Haas,Daniel Cejka

Sclerostin Declines during Hemodialysis and Appears in Dialysate

2014

Bernhard Bielesz
Till Hempfing
Heidi Kieweg
Rodrig Marculescu
Martin Haas
Daniel Cejka

Background/Aims: Sclerostin, a soluble inhibitor of Wnt-signaling, inhibits bone formation. We assessed the impact of dialysis on serum sclerostin and whether scl

Keywords:

Dialysis
Dialysis solutions
Diabetes mellitus
Parathyroid hormone
Hemodialysis
Endocrinology
Internal medicine
Sclerostin
Medicine
bone formation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations